维普期刊资源整合服务平台（V6.5）

150篇 您的检索式：作者名="Vukelja"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Randomized phase Ⅱ study of weekly irinotecan/carboplatin with or without cetuximab in patients with metastatic breast cancer ( abstract 308 ) 显示文摘	O' Shaughnessy J Weckstein DJ Vukelja SJ	2007	Breast Cancer Res Treat2007，106，1：	1
2	Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer:phase Ⅲ trial results显示文摘	D'shaughnessy J Miles D Vukelja s	2002	J Clin Oncol2002，20，12：	1
3	Superior survival with capecitabine plus docetaxel combination therapy in anthracycline -pretreatded patients with advanced breast cancer: Phase Ⅲ trial results 显示文摘	O'shoughnessy J Miles D Vukelja S	2002	J Clin Oncol2002，20，12：	1
4	Superior survival with capeicitabine plus docetaxel combination therapy inanthracycline-pretreated patients with advanced breast cancer phase trial results显示文摘	O'Shaughnessy J Miles D VukeljaS	2002	J ClinOncol2002，20，12：	1
5	Phase Ⅱ trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy显示文摘	BLUM J L DEES E C VUKELJA S J	2007	Clin Breast Cancer2007，7，6：	1
6	Angiofollicular lymph node hyperplasia( Castleman disease) 显示文摘	MeCarty MJ Vukelja SJ Banks PM	1995	Cancer Treat Rev1995，21，4：	1
7	Superior suivival with capecitabine plus docetacel combination therapy in anthracyclinepretreated patients with advanced breast cancer:Phase 3 trial results显示文摘	O' Shaughnessy J Miles D Vukelja S		J Clin Oncol0，2002，：	1
8	Phase II study of the an- tibody drug conjugate trastuzumab- DM1 for the treatment of hu- man epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2--directed therapy显示文摘	Burris HA 3rd Rugo HS Vukelja SJ	2011	J Clin Oncol2011，29，4：	1
9	Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy显示文摘	O'Shaughnessy JA Vukelja SJ Holmes FA	2005	Clin Breast Cancer2005，5，6：	1
10	Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy显示文摘	O′Shaughnessy J A Vukelja S J Holmes F A	2005	Clin Breast Cancer2005，5，6：	1
11	Superior survival with capectitabine plus docctaxel combination therapy in anthracycline- pretTeated patients with advanced breast cancer:phase III trial resuits显示文摘	O' Shaughnessy J Miles D Vukelja S	2002	J Clin Oncol2002，20，：	1
12	Superior survivetal with capecitabine plus docetaxel combination therapy in anthracycline pretreated patients with advanced breast cancer:phase (A) trietal results显示文摘	O'shaughnessy J Miles D Vukelja S	2002	J Clin Oncol2002，20，12：	1
13	Superior survival with capeicitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phaseⅢtrial results显示文摘	OW SHAUGHNESSY J MILES D VUKELJA S	2002	J Clin Oncol2002，20，12：	1
14	Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer:phase Ⅲ trial results显示文摘	O'Shaughnessy J Miles D Vukelja S	2002	J Clin Oncol2002，20，12：	1
15	Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase Ⅲtrial results 显示文摘	O' Shaughnessy J Miles D Vukelja S	2002	J Ciin Oncol2002，20，12：	1
16	Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adju- vant Multicenter trial substudy 显示文摘	Jones SE Cantrell J Vukelja S	2007	Journal of Clinical Oncol2007，25，30：	1
17	Blinded,randomized,multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer显示文摘	HOLMES FA O'SHAUGHNESSY JA VUKELJA S	2002	J Clin Oncol2002，20，3：	1
18	Blinded, randomized, multieenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer显示文摘	Holmes FA O' Shaughnessy JA Vukelja S	2002	J Clin Oncol2002，20，3：	1
19	Superior survival with capeicitabine plus docetaxel combination therapy in anthracycline- pretreated patients with advanced breast cancer: phase m trial re- sults显示文摘	O' Shaughnessy J Miles D Vukelja S	2002	JClin 0ncol2002，20，12：	1
20	Blinded,randomized,multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer显示文摘	Holmes FA O'Shaughnessy JA Vukelja S	2002	J Clin Oncol2002，20，3：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示